SphingoTec GmbH has received its IVDR certificate for its sphingotest® penKid® confirming the quality and compliance of this product with regulatory requirements.Sphingotest® penKid® aids in the diagnosis
Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury 04.04.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. The Acute Disease Qualit.
Issuer: SphingoTec GmbH / Key word(s): Study results/Research Update Liberation from renal replacement therapy and early initiation to be supported by the kidney function biomarker Proenkephalin
Issuer: SphingoTec GmbH / Key word(s): Agreement/Contract Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid) 15.11.2022